RYBELSUS 7 MG COM OR CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1176600370064 -
GGREM
526620120009507 -
Código de barras
7897705202715
O que a fonte publica
- Detentor do registro
- NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
- Princípios ativos
- SEMAGLUTIDA
- Embalagem
- 7 MG COM OR CT BL AL AL X 30
- Tipo de produto
- Biológico
- Classe terapêutica
- A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYBELSUS 7 MG COM OR CT BL AL AL X 30",
"holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
"stripe": null,
"barcodes": [
"7897705202715"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526620120009507",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "82.277.955/0001-55",
"priceRegime": "Regulado",
"productName": "RYBELSUS",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "7 MG COM OR CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "860.83",
"icms-12": "978.22",
"icms-17": "1037.14",
"icms-18": "1049.79",
"icms-19": "1062.75",
"icms-20": "1076.04",
"icms-21": "1089.66",
"icms-22": "1103.63",
"icms-23": "1117.96",
"icms-17.5": "1043.43",
"icms-19.5": "1069.35",
"icms-20.5": "1082.81",
"icms-22.5": "1110.75",
"icms-12-alc": "873.41",
"icms-17-alc": "926.02",
"icms-18-alc": "937.31",
"icms-19-alc": "948.89",
"icms-20-alc": "960.75",
"icms-21-alc": "972.91",
"icms-22-alc": "985.38",
"icms-23-alc": "998.18",
"withoutTaxes": "768.60",
"icms-17.5-alc": "931.63",
"icms-19.5-alc": "954.78",
"icms-20.5-alc": "966.79",
"icms-22.5-alc": "991.74"
},
"pisCofinsList": "Negativa",
"substanceText": "SEMAGLUTIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1154.77",
"icms-12": "1312.25",
"icms-17": "1391.29",
"icms-18": "1408.26",
"icms-19": "1425.64",
"icms-20": "1443.47",
"icms-21": "1461.74",
"icms-22": "1480.48",
"icms-23": "1499.70",
"icms-17.5": "1399.72",
"icms-19.5": "1434.49",
"icms-20.5": "1452.55",
"icms-22.5": "1490.03",
"icms-12-alc": "1207.44",
"icms-17-alc": "1280.17",
"icms-18-alc": "1295.78",
"icms-19-alc": "1311.78",
"icms-20-alc": "1328.18",
"icms-21-alc": "1344.99",
"icms-22-alc": "1362.23",
"icms-23-alc": "1379.93",
"withoutTaxes": "1062.54",
"icms-17.5-alc": "1287.92",
"icms-19.5-alc": "1319.93",
"icms-20.5-alc": "1336.53",
"icms-22.5-alc": "1371.02"
},
"invalidBarcodes": [],
"activeSubstances": [
"SEMAGLUTIDA"
],
"therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1176600370064",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "A10S",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526620120009507"